Medtech Recalls Clear Eyes Redness Relief Eye Drops for Quality Control Issues
Medtech Products, Inc. is recalling Clear Eyes Redness Relief eye drops due to concerns about quality assurance controls in the manufacturing facility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the source text cites manufacturing quality control deviations without reporting specific illnesses or injuries, fitting the criteria for a moderate severity precautionary recall.
Plain-English summary
Medtech Products, Inc. is recalling 314,112 bottles of Clear Eyes Redness Relief Hand Pocket Pal eye drops. The affected products are 0.2 FL OZ (6 mL) bottles containing Glycerin 0.25% and Naphazoline hydrochloride 0.012%. The recall covers specific lots with expiration dates of 02/20, 04/20, and 05/20.
The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations. Specifically, there are concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility, which could impact the quality of the finished products.
The products were distributed nationwide in the USA and Puerto Rico, as well as in St. Michael, Barbados, Guyana, St. Johns, Antigua and Barbuda, Kingston 5, and Jamaica. Consumers should check their lot numbers and expiration dates against the recalled list and stop using the product if it matches the recalled description.
The recalled product
- Product
- Clear Eyes Redness Relief Hand Pocket Pal Tray Display; each display (UPC 6 78112 25418 7) contains 48 each of Clear eyes REDNESS RELIEF (Glycerin 0.25%, Naphazoline hydrochloride 0.012%) eye drops, 0.2 FL OZ (6 mL) bottle, Handy Pocket Pal (UPC 6 78112 25418 7); Distributed by…
- Manufacturer
- Medtech Products, Inc.
- Category
- Drug — Ophthalmic
- Hazard
- Affected units
- 314,112
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot #: 17051
- Exp 02/20
- 17130
- Exp 04/20
- 17147
- Exp 05/20
Distribution
Part of a larger recall action
This product is one of 14 recalled by Medtech Products, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 14 products in this recall →Related recalls
Same manufacturer · Medtech Products, Inc.
See all →- ModerateMedtech Recalls Clear Eyes Maximum Itchy Eye Relief Drops
FDA (Drugs) · 2019-08-28
- ModerateMedtech Recalls Clear Eyes Maximum Redness Relief Eye Drops
FDA (Drugs) · 2019-08-28
- ModerateMedtech Recalls Clear Eyes Assorted Displays Due to Quality Control Concerns
FDA (Drugs) · 2019-08-28
- ModerateMedtech Recalls Clear Eyes Redness Relief Eye Drops for Quality Concerns
FDA (Drugs) · 2019-08-28
- ModerateMedtech Recalls Clear Eyes Redness Relief Eye Drops for Quality Control Issues
FDA (Drugs) · 2019-08-28
Same hazard · quality control
See all →- HighBaxter Recalls CARDENE IV Nicardipine Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateMylan Recalls Mycophenolate Mofetil Injection Due to Dissolution Failures
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls MYXREDLIN Insulin Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Vasopressin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
Similar recalls
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereClear Eyes Redness Relief Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2019-11-27
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Assurance Issues
FDA (Drugs) · 2026-09-30
- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- HighGNP redness and dry eye relief drops recalled over sterility assurance
FDA (Drugs) · 2026-04-08
- SevereClear Eyes Redness Relief Recalled Due to Sterility Assurance Issues
FDA (Drugs) · 2019-11-27